---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-035170"
form_type: "8-K"
ticker: "PLSE"
cik: "0001625101"
company_name: "PULSE BIOSCIENCES, INC."
filed_at: "2023-12-22T23:59:59+00:00"
generated_at: "2026-06-07T07:56:47.585605+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Pulse Biosciences stockholders approve equity plan amendment and ratify executive option grants

## Summary
- Proposal 1 (increase share reserve by 1,375,000 shares) passed with 38.3M for, 2.97M against.
- Proposal 2 (ratify options for 1,505,000 shares at $4.38) passed with 39.2M for, 2.06M against.
- Ratified options include grants to CEO Kevin Danahy (460,000), Darrin Uecker (330,000), Mitchell Levinson (100,000).
- Options have 10-year term, vest at 6-year anniversary or 1-year after change in control.

## SEC filing metadata
- accession: 0001437749-23-035170
- form_type: 8-K
- ticker: PLSE
- cik: 0001625101
- company_name: PULSE BIOSCIENCES, INC.
- filed_at: 2023-12-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625101/000143774923035170/0001437749-23-035170-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625101/000143774923035170/plse20231219_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-035170
- JSON: https://secwatch.observer/filing/0001437749-23-035170.json
- Plain text: https://secwatch.observer/filing/0001437749-23-035170.txt

## Key facts
- Shareholder Votes
  PULSE BIOSCIENCES, INC. shareholders approved Approve amendment to 2017 Equity Incentive Plan to increase shares by 1,375,000 at the 2023-12-19 meeting.
  - Proposal: equity plan
  - Outcome: passed
  - Meeting: 2023-12-19
  source text: Proposal 1. Amendment of the Equity Plan For Against Abstained Broker Non-votes 38,301,130 2,970,156 4,396 N/A
  evidence_url: https://www.sec.gov/Archives/edgar/data/1625101/000143774923035170/0001437749-23-035170-index.htm
- Shareholder Votes
  PULSE BIOSCIENCES, INC. shareholders approved Ratify options awarded on November 1, 2023 under the Equity Plan at the 2023-12-19 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-12-19
  source text: Proposal 2. Ratification of Award For Against Abstained Broker Non-votes 39,206,759 2,064,323 4,600 N/A
  evidence_url: https://www.sec.gov/Archives/edgar/data/1625101/000143774923035170/0001437749-23-035170-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.